Biomarker correlates of clinical response with FLT3L/nivo backbone treatment in the multi-cohort phase 1 porter platform trial in metastatic castration-resistant prostate cancer patients Meeting Abstract
| Authors: | Shotts, K.; Howes, T.; Yu, J.; Densmore, J.; Da Silva, D.; Kumar, D.; Santulli-Marotto, S.; Cabanski, C.; Eisenbeisz, E.; Ivison, G.; Mayer, A.; Moore, J.; Jones, D.; Kraynyak, K.; Dolgoter, A.; Chen, R.; Butterfield, L.; LaVallee, T.; Bucktrout, S.; Padron, L.; Dugan, U.; Yellin, M.; Keler, T.; O'Donnell-Tormey, J.; Fairchild, J.; Salvador, L.; Wentzel, K.; Fong, L.; Subudhi, S.; Bhardwaj, N.; Autio, K.; Galsky, M. |
| Abstract Title: | Biomarker correlates of clinical response with FLT3L/nivo backbone treatment in the multi-cohort phase 1 porter platform trial in metastatic castration-resistant prostate cancer patients |
| Meeting Title: | 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 10 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Nov 8-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2022-11-01 |
| Start Page: | A585 |
| Language: | English |
| ACCESSION: | WOS:000919423400526 |
| DOI: | 10.1136/jitc-2022-SITC2022.0559 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 559 -- Source: Wos |
